Parkinson’s disease is caused by the progressive death of dopamine-producing nerve cells deep in the brain, but what triggers that cell death isn’t a single factor. In roughly 85% of cases, no clear inherited cause can be identified. The remaining 15% have a family history pointing to specific genetic mutations. For most people, Parkinson’s appears to result from a combination of genetic vulnerability, environmental exposures, and aging processes that converge to destroy a particular group of neurons over many years.
What Happens Inside the Brain
The core problem in Parkinson’s is the loss of neurons in a small, darkly pigmented structure called the substantia nigra, located in the base of the brain. These neurons produce dopamine, a chemical messenger that coordinates smooth, controlled movement. As they die off, dopamine levels drop, and the familiar motor symptoms appear: tremor, stiffness, slowness, and difficulty with balance.
By the time someone notices tremor or shuffling steps, an estimated 60% to 80% of these dopamine neurons are already gone. The disease has been silently progressing for years, possibly decades, before the first visible symptoms.
The Role of Protein Clumping
Inside the affected neurons, researchers consistently find abnormal clumps called Lewy bodies. These are dense, round structures made primarily of a misfolded protein called alpha-synuclein, along with lipids, damaged mitochondria (the cell’s energy factories), and fragments of the cell’s recycling machinery.
The formation of these clumps is more than just a byproduct of disease. Research published in PNAS found that the process of building Lewy bodies, not simply the presence of misfolded protein fibers, is one of the major drivers of nerve cell death. As these inclusions grow, they trap proteins and organelles the cell needs to function, disrupting energy production and communication between neurons. The resulting damage is slow but relentless, producing a gradual cell death response rather than a sudden collapse.
Genetic Mutations That Raise Risk
About 15% of people with Parkinson’s have a family history of the condition. In these families, mutations in specific genes can dramatically increase risk. The most well-studied include LRRK2, SNCA (the gene that makes alpha-synuclein), PINK1, PARK2, and PARK7. Some of these mutations cause early-onset Parkinson’s, appearing before age 50, while others raise risk for the more common later-onset form.
The SNCA gene is particularly telling. Mutations that cause the body to produce too much alpha-synuclein, or a slightly altered version of it, lead directly to the protein clumping seen in Lewy bodies. PINK1 and PARK2 mutations, on the other hand, impair the cell’s ability to clear out damaged mitochondria, leaving neurons vulnerable to energy failure.
Still, carrying one of these mutations doesn’t guarantee you’ll develop Parkinson’s. Many carriers never do. This means other factors, environmental, lifestyle, or simply luck in cellular aging, play a deciding role even when genetic risk is present.
Environmental Toxins and Chemical Exposures
For the majority of cases without a clear genetic link, environmental exposures are among the strongest risk factors identified. Paraquat, an herbicide widely used in agriculture, has mounting evidence connecting it to Parkinson’s risk. Scientists have used paraquat and another pesticide called rotenone to reliably produce Parkinson’s-like damage in laboratory animals for decades, confirming these chemicals are directly toxic to dopamine neurons.
Trichloroethylene, an industrial solvent used in metal degreasing and chemical manufacturing, has also been linked to increased risk. These chemicals damage neurons through several overlapping mechanisms: they generate harmful free radicals that attack cell structures, they impair mitochondria so neurons can’t produce enough energy, and they trigger chronic inflammation that injures surrounding tissue.
Perhaps most importantly, researchers are finding that pesticide exposure can accelerate the clumping of alpha-synuclein. In animal models, certain pesticides increase misfolding and aggregation of this protein, creating a direct biological bridge between environmental toxins and the hallmark pathology of Parkinson’s. This suggests that chemical exposures don’t just damage neurons randomly. They may kick-start the same disease process seen in genetic forms.
The Gut-Brain Connection
One of the most provocative findings in recent Parkinson’s research is the possibility that the disease begins not in the brain but in the gut. The gut has its own extensive network of nerve cells, and alpha-synuclein deposits have been found in the intestinal nervous system of Parkinson’s patients, sometimes years before brain symptoms appear.
The hypothesis, first proposed by neuroanatomist Heiko Braak, suggests that an environmental trigger (perhaps a pathogen or toxin) passes through the intestinal lining and causes alpha-synuclein to misfold in gut neurons. From there, the misfolded protein travels upward along the vagus nerve, a major highway connecting the gut to the brain, eventually reaching the substantia nigra and other vulnerable regions. Animal experiments support this: injecting aggregated alpha-synuclein into the intestinal wall of rodents triggers accumulation of the protein in brain regions over time, spreading in a predictable, region-by-region pattern.
A striking piece of supporting evidence comes from studies of patients who had their vagus nerve surgically cut (a procedure once used to treat peptic ulcers). These patients had a lower incidence of Parkinson’s compared to people who hadn’t had the surgery, suggesting that severing this nerve pathway may block the disease from reaching the brain.
Head Injuries as a Risk Factor
Traumatic brain injury also increases Parkinson’s risk. People who have experienced a mild traumatic brain injury face about 1.5 times the risk of developing Parkinson’s compared to those who haven’t. For severe brain injuries, that figure rises to 1.8 times the risk. The mechanism likely involves triggering or accelerating the inflammatory and protein-clumping processes that underlie the disease, though the connection is clearest in the years immediately following injury.
Early Clues the Disease Has Already Started
Because Parkinson’s develops over many years before motor symptoms appear, the body often shows earlier, subtler signs. Loss of smell, chronic constipation, and depression are among the earliest non-motor symptoms, sometimes appearing a decade or more before tremor or stiffness. A condition called REM sleep behavior disorder, where people physically act out vivid dreams by kicking, punching, or shouting during sleep, is one of the strongest early predictors.
When REM sleep behavior disorder occurs alongside a diminished sense of smell, the likelihood of eventually developing Parkinson’s or a related condition called dementia with Lewy bodies increases substantially. These early symptoms reflect the fact that alpha-synuclein pathology is already spreading through nerve pathways that control smell, digestion, and sleep regulation long before it reaches the motor control centers of the brain. This timeline reinforces the idea that Parkinson’s is a whole-body disease, not just a brain disease, and that its causes set a long, slow process in motion years before diagnosis.